Background: Randomised controlled trials have demonstrated significant reductions in
Introduction
In the UK, colorectal cancer (CRC) is the fourth most common incident cancer and second most common cause of cancer-related death.(1) The UK has inferior CRC survival rates to comparable countries, commonly attributed to later clinical presentation.(2, 3) CRC typically originates from precancerous colorectal polyps, providing an opportunity for prevention if detected early and successfully excised.
The vast majority of colorectal polyps are either adenomas or hyperplastic polyps. (4) Adenomas are dysplastic polyps which can progress via the adenoma-carcinoma sequence to invasive cancer. Hyperplastic polyps are classified within the serrated group of colorectal polyps, and are traditionally considered benign. A related subtype of serrated polyps, namely sessile serrated polyps (also known as sessile serrated adenomas), may progress to carcinoma via the serrated carcinogenesis pathway, (5, 6 ) but these are relatively rare.(7) Individuals who have only hyperplastic polyps removed at endoscopy are not typically entered into surveillance.(8) Individuals with adenomas detected will usually be entered into a surveillance regime at an interval of 1, 3 or 5 years primarily depending on the number and size of adenomas detected or genetic predisposition to CRC. (8, 9) The ultimate aim of clearing the bowel of adenomas, and entering patients into surveillance, is to reduce CRC risk. Building upon the historic findings of Winawer and colleagues, (10) several recent randomised controlled trials (11) (12) (13) (14) and population-based case-control studies (15, 16) have demonstrated the success of polypectomy in reducing CRC risk. The US Prostate, Lung, Colorectal and Ovarian cancer screening trial has reported a significant 21% reduced risk of CRC amongst the intervention arm who underwent flexible sigmoidoscopy at baseline plus 3 or 5 years later, compared with usual care.(11) A 'one-off' flexible sigmoidoscopy was also effective at reducing CRC risk by 23% in a UK trial, (12) while similar reductions were observed in Italian, but not Norwegian, trials. (13, 14) However, little is known about whether polypectomy is effective at reducing CRC risk in routine clinical practice. The aforementioned trials (11) (12) (13) (14) and case-control studies (15, 16) may incur selection bias due to modest response rates limiting the likelihood of participants being representative of the general population. Few studies have investigated CRC risk following polypectomy in the general population. A French study observed a 2.2-fold greater incidence of CRC amongst advanced adenoma patients compared with the general population,(17) whilst a large Dutch study concluded that excess CRC risk in adenoma patients was limited to the first few years of follow-up. (18) In addition, given the enhanced opportunity for polyp detection within bowel cancer screening programmes, (19, 20) the appropriate clinical management of patients following polypectomy is even more pertinent.
The aim of this investigation was to quantify CRC risk following polypectomy of adenomas in a large population-based study.
Materials and Methods

Subject classification
The Northern Ireland colorectal polyp register (NICPR) was derived from electronic pathology reports relating to all colorectal biopsies within Northern Ireland between 2000 and 2005. The NICPR has ethical approval from ORECNI: 10/NIR02/53. This timeframe precedes bowel cancer screening in this region, and therefore reflects clinical investigation of a symptomatic population. As outlined in Figure 1 , relevant SNOMED morphology codes for adenomas and hyperplastic polyps were extracted. Few polyps were diagnosed or coded as sessile serrated polyps during this time period, and therefore these were excluded from analysis. Individuals aged <16 years were also removed. We applied two strategies for identifying and excluding patients who may be genetically predisposed to CRC due to polyposis syndromes. Firstly, patients were removed from the NICPR if they attended a genetic follow-up service at the Belfast Health and Social Care Trust (the sole referral centre in Northern Ireland). Secondly, we conducted a medical note review as part of a nested case-control study (described in detail below) to identify participants with a personal or family history of colorectal polyps or polyposis syndromes.
Patients were categorised into an 'adenoma register' if their incident polyp was recorded as an adenomatous polyp(s) with or without a concurrent hyperplastic polyp(s) diagnosis. Patients who only received a hyperplastic polyp diagnosis were grouped into a 'hyperplastic polyp register'. SNOMED coding was used to identify tubular, tubulovillous or villous adenoma subtypes. Information on polyp size was not readily available, and so patients with 'advanced risk' adenomas were considered to be those with multiple adenomas of any histological type or at least one adenoma including a villous component i.e. villous or tubulovillous. In order to minimise misclassification of polyps detected but not removed at first investigation, all polyps detected within six months of the baseline polyp were reclassified as 'incident' polyps. Subsequent polyps were those diagnosed at least six months after incident polyps, and up to for an undiagnosed polyposis syndrome) were excluded from further nested case-control study analysis due to the likelihood that they are genetically predisposed to CRC. We did not exclude individuals reporting a family history of CRC, since only a small proportion (5-10%)(21) of these cases are likely to be due to genetic conditions and a known family history may simply reflect shared lifestyle or other non-hereditary CRC risk factors between family members.
Cases for whom we were able to retrieve notes to enable inclusion within the case-control study did not differ from those not included with respect to age, sex, polyp location, morphology or advanced status, and are therefore representative of the entire CRC case set.
Statistical analysis
Patients were followed up from the date of their incident polyp diagnosis (excluding the first six months of follow-up) until their date of CRC diagnosis, date of death or 31 st December 2010. Descriptive characteristics were compared using independent t-tests and chi-squared tests for continuous and categorical variables, respectively. Individuals with less than six months follow-up were excluded from analysis. CRC incidence was calculated per 100-person years of follow-up, comparing observed incidence with that of expected incidence in the Northern Ireland population between 2000 and 2010. Cox proportional hazards models were applied to investigate the association between CRC risk and demographics or incident polyp characteristics. Stratified analysis was conducted by these variables to explore effect modification. Assumptions for Cox proportional hazards models were checked by visual inspection of Kaplan-Meier plots.
Standardised CRC incidence ratios (SIRs) and corresponding 95% confidence intervals (CI) were analysed per 100,000 population, and separately for males and females. Sensitivity analysis was performed after excluding those with less than one year of follow-up. For the nested case-control study, CRC risk was assessed between comparative groups by applying conditional logistic regression analysis to generate odds ratios (OR) and 95% CI. Statistical analysis was conducted using Intercooled Stata version 11.0 (StataCorp, College Station, TX, USA).
Results
Over a six year time period, n=6,972 individuals had a least one adenoma removed at their index colonoscopic investigation ( Figure 1 ). There was a slight male predominance for adenoma patients, and the mean age at adenoma removal was 62.3 years. The majority of adenomas were detected and removed from the colon, and 22% of individuals had multiple adenomas removed at their first investigation in this time period (Table 1) .
During a total of 44,724 person-years of follow-up, 193 patients were diagnosed with incident CRC. The rate of progression was relatively stable over time, and was consistently higher in males than females ( Figure 2 ). Over this period, 0.43% of adenoma patients developed CRC each year, as shown in Table 2 . CRC risk was significantly elevated in males and in individuals aged 60 years or older with adenomas. Rectal adenoma patients had an increased CRC risk (HR 1.70; 95% CI: 1.27-2.28) compared with those who had only colonic adenomas excised.
No CRC developed in patients who had adenomas removed from both the colon and rectum.
Those with tubulovillous or villous adenomas were more likely to develop CRC compared with those with tubular adenomas (HR 1.51; 95% CI: 1.02-2.23).
Several factors were associated with reduced risk of CRC amongst adenoma cases, including being diagnosed with concurrent hyperplastic polyps (HR 0.45; 95% CI: 0.24-0.82), or subsequent polyps (Table 2 ). Individuals diagnosed with multiple incident adenomas also had a decreased risk of CRC (HR 0.67; 95% CI: 0.45-0.97). Sensitivity analysis removing the first year of follow-up revealed largely similar results (Supplementary Table 1 ). As shown in Table   2 , the risk of progression to CRC was lower in patients diagnosed with only hyperplastic polyps (0.17% per year), compared with adenoma patients. CRC risk in hyperplastic polyp patients did not differ significantly by sex, polyp location or multiplicity, however individuals aged 60-<80 years were at significantly increased risk of CRC compared with younger patients (data not shown).
As outlined in Table 3 A post-hoc nested case-control study was conducted amongst CRC cases arising in adenoma and hyperplastic polyp cases (n=193, 82.5%) and matched controls whose medical notes were available for review, to determine further factors that may explain the excess CRC risk. A small number of CRC cases were identified to have a personal history of polyposis syndromes (n=3) or family history of colorectal polyps (n=7), or both (n=1) and were excluded from further analysis since they are likely to be genetically predisposed to a greater CRC risk, leaving n=148 case-control pairs in the remaining adenoma analysis and n=34 pairs in the hyperplastic polyp analysis. As shown in (Table 4) .
Non-significant increased CRC risks were observed for individuals with multiple and/or rightsided hyperplastic polyps, and those who did not attend for a planned follow-up investigation (data not shown).
Discussion
Overall, annual CRC risk amongst individuals following polypectomy of adenomas in the nonscreening setting is 0.43%. Despite undergoing polypectomy, CRC risk is significantly elevated for incident adenoma patients compared with the general population.
The increased risk of CRC following adenoma removal observed in our study is in line with findings from a French study. (17) Other factors that would be expected to increase CRC risk, including a personal history of inflammatory bowel disease, presence of high-grade dysplasia in the adenomas and large adenoma size, (9, 25) were directly associated with CRC risk in the detailed case note review aspect of our study. All of these findings are reassuring for the robustness of our data, but collectively, these factors only account for a relatively small proportion of the excess CRC cases found in this population. Our study has several strengths, including its large size, length of follow-up and relevance to current practice, given the timeframe of adenoma patients studied. The population-based nature of the study is important to emphasise, demonstrating CRC risk following polypectomy in a 'real world' setting. This is the first insight into this association in a UK population, amongst whom healthcare is free at the point of access. Northern Ireland has a relatively stable population with limited migration, (40) In conclusion, this large population-based study demonstrates that CRC risk remains significantly higher than that of the general population following adenoma removal, outside of screening programmes. Our findings suggest the increased CRC risk may be partially due to incomplete examination and/or adherence to follow-up colonoscopies. There is a need for full colonoscopy and adenoma clearance after a diagnosis of colorectal adenoma to reduce risk of subsequent CRC. Further research is required to identify optimal surveillance protocols, and adherence to these, following adenoma removal. Incorporates n=858 individuals diagnosed with concurrent hyperplastic polyps as outlined in Figure 1 . These are excluded from the ≥2 polyp number category unless multiple adenomas were diagnosed. b Percentages may not total 100 due to rounding. c Individuals with ≥1 villous or tubulovillous adenoma were classified as villous/tubulovillous, even if they also had a tubular adenoma at incident diagnosis. Incorporates n=858 individuals diagnosed with concurrent hyperplastic polyps as outlined in Figure 1 .
B Individuals with multiple adenomas or ≥1 villous/tubulovillous adenomas were classified as advanced. The polyp register did not contain detailed information on polyp size. Chosen as reference category to reflect that many individuals attended for a sigmoidoscopy or other non-full colonoscopy investigation at their first investigation, which was then followed up by a full colonoscopy.
